Drugs / GKL-006RTU
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07706855 | Jul 2026 → Jul 2027 expected | acute respiratory distress syndrome | Beijing Gene Key Life Technology Co., Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GKL-006RTU | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07706855 ↗ |
| Modality | Cell therapy | “iNKT cell injection” NCT07706855 ↗ |
| Route | Intravenous | “single intravenous infusion of GKL-006RTU injection” NCT07706855 ↗ |